Loading…

Obstetric outcomes in a Mexican cohort of patients with AQP4-antibody-seropositive neuromyelitis optica

•Close to half of the patients with previous pregnancies reported at least one gestational loss. This percentage is higher than expected for their age group in our country.•Most of these pregnancy losses occurred years before the diagnosis of NMO.•AQP4-IgG can be detected in serum more than 10 years...

Full description

Saved in:
Bibliographic Details
Published in:Multiple sclerosis and related disorders 2018-10, Vol.25, p.268-270
Main Authors: Delgado-García, Guillermo, Chávez, Zoé, Rivas-Alonso, Verónica, Corona, Teresa, Flores-Rivera, José
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c359t-ef5001ef67054da9c9bccd6fd90074ba775ad65df91e321086a934b62c12afb43
cites cdi_FETCH-LOGICAL-c359t-ef5001ef67054da9c9bccd6fd90074ba775ad65df91e321086a934b62c12afb43
container_end_page 270
container_issue
container_start_page 268
container_title Multiple sclerosis and related disorders
container_volume 25
creator Delgado-García, Guillermo
Chávez, Zoé
Rivas-Alonso, Verónica
Corona, Teresa
Flores-Rivera, José
description •Close to half of the patients with previous pregnancies reported at least one gestational loss. This percentage is higher than expected for their age group in our country.•Most of these pregnancy losses occurred years before the diagnosis of NMO.•AQP4-IgG can be detected in serum more than 10 years before the NMO onset and can cause miscarriage by binding to placental AQP4, activating complement, and causing inflammatory infiltration. Background: Previous studies have investigated the influence of neuromyelitis optica (NMO) on pregnancy in other ethnic groups. However, there are potential variations among ethnic groups. The obstetric outcome of Mexican patients with NMO and AQP4-IgG positivity (AQP4-IgG[+]) is currently unknown. Objective: To describe the obstetric history of Mexican patients with NMO and AQP4-IgG(+). Methods: Patients with NMO and AQP4-IgG(+) were identified from the database of the Demyelinating Diseases Clinic. These patients were interviewed by telephone. Results: Out of a total of 40 eligible patients, 29 were contacted and completed the survey. Of these, 19 patients reported at least one previous pregnancy. In total, 50 pregnancies were reported: 44 of them occurred ≥ 3 years before the first clinical manifestation, 1 occurred ≥ 1 years before, and 1 occurred after the first manifestation. Of all pregnancies, 12 were pregnancy losses: 5 were classified as miscarriages and 3 as stillbirths. Of all pregnancy losses, 10 occurred ≥ 3 years before the diagnosis, 1 occurred after the first manifestation. All pregnancy losses occurred in 8 patients. Conclusions: Close to half of the patients with previous pregnancies reported at least one pregnancy loss, most of these occurred ≥ 3 years before the diagnosis. This percentage is higher than expected for their age group in our country.
doi_str_mv 10.1016/j.msard.2018.08.015
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2095542385</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2211034818302931</els_id><sourcerecordid>2095542385</sourcerecordid><originalsourceid>FETCH-LOGICAL-c359t-ef5001ef67054da9c9bccd6fd90074ba775ad65df91e321086a934b62c12afb43</originalsourceid><addsrcrecordid>eNp9kE1rGzEQhkVpaEySX1AIOvayzmj1Ye8hB2OaJpCSBNqz0EqzjYx3tZW0Sf3vK8epjx0GZgbeeYd5CPnMYM6AqavNvE8munkNbDmHkkx-ILO6ZqwCLtXHYy-Wp-QipQ2UUJIJxT6RUw5MNBz4jPx6aFPGHL2lYco29JioH6ih3_GPt2agNjyHmGno6GiyxyEn-urzM109PYrKDNm3we2qhDGMIfnsX5AOOMXQ73BbxkTDmIvROTnpzDbhxXs9Iz9vvv5Y31b3D9_u1qv7ynLZ5Ao7CcCwUwuQwpnGNq21TnWuAViI1iwW0jglXdcw5DWDpTINF62qLatN1wp-Rr4cfMcYfk-Ysu59srjdmgHDlHQNjZSi5ktZpPwgtTGkFLHTY_S9iTvNQO8h641-g6z3kDWUZPuty_cDU9ujO-78Q1oE1wcBljdfPEadbOFm0fmINmsX_H8P_AXYn5AA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2095542385</pqid></control><display><type>article</type><title>Obstetric outcomes in a Mexican cohort of patients with AQP4-antibody-seropositive neuromyelitis optica</title><source>ScienceDirect Journals</source><creator>Delgado-García, Guillermo ; Chávez, Zoé ; Rivas-Alonso, Verónica ; Corona, Teresa ; Flores-Rivera, José</creator><creatorcontrib>Delgado-García, Guillermo ; Chávez, Zoé ; Rivas-Alonso, Verónica ; Corona, Teresa ; Flores-Rivera, José</creatorcontrib><description>•Close to half of the patients with previous pregnancies reported at least one gestational loss. This percentage is higher than expected for their age group in our country.•Most of these pregnancy losses occurred years before the diagnosis of NMO.•AQP4-IgG can be detected in serum more than 10 years before the NMO onset and can cause miscarriage by binding to placental AQP4, activating complement, and causing inflammatory infiltration. Background: Previous studies have investigated the influence of neuromyelitis optica (NMO) on pregnancy in other ethnic groups. However, there are potential variations among ethnic groups. The obstetric outcome of Mexican patients with NMO and AQP4-IgG positivity (AQP4-IgG[+]) is currently unknown. Objective: To describe the obstetric history of Mexican patients with NMO and AQP4-IgG(+). Methods: Patients with NMO and AQP4-IgG(+) were identified from the database of the Demyelinating Diseases Clinic. These patients were interviewed by telephone. Results: Out of a total of 40 eligible patients, 29 were contacted and completed the survey. Of these, 19 patients reported at least one previous pregnancy. In total, 50 pregnancies were reported: 44 of them occurred ≥ 3 years before the first clinical manifestation, 1 occurred ≥ 1 years before, and 1 occurred after the first manifestation. Of all pregnancies, 12 were pregnancy losses: 5 were classified as miscarriages and 3 as stillbirths. Of all pregnancy losses, 10 occurred ≥ 3 years before the diagnosis, 1 occurred after the first manifestation. All pregnancy losses occurred in 8 patients. Conclusions: Close to half of the patients with previous pregnancies reported at least one pregnancy loss, most of these occurred ≥ 3 years before the diagnosis. This percentage is higher than expected for their age group in our country.</description><identifier>ISSN: 2211-0348</identifier><identifier>EISSN: 2211-0356</identifier><identifier>DOI: 10.1016/j.msard.2018.08.015</identifier><identifier>PMID: 30149303</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Abortion ; Adult ; Aquaporin 4 ; Aquaporin 4 - immunology ; Autoantibodies - blood ; Female ; Hispanics ; Humans ; Immunologic Factors - adverse effects ; Mexico - epidemiology ; Middle Aged ; Neuromyelitis optica ; Neuromyelitis Optica - blood ; Neuromyelitis Optica - complications ; Neuromyelitis Optica - drug therapy ; Obstetric Labor Complications - epidemiology ; Obstetric Labor Complications - etiology ; Pregnancy ; Pregnancy complications ; Pregnancy outcome ; Spontaneous abortion</subject><ispartof>Multiple sclerosis and related disorders, 2018-10, Vol.25, p.268-270</ispartof><rights>2018</rights><rights>Copyright © 2018. Published by Elsevier B.V.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c359t-ef5001ef67054da9c9bccd6fd90074ba775ad65df91e321086a934b62c12afb43</citedby><cites>FETCH-LOGICAL-c359t-ef5001ef67054da9c9bccd6fd90074ba775ad65df91e321086a934b62c12afb43</cites><orcidid>0000-0002-3123-5879</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,786,790,27957,27958</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30149303$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Delgado-García, Guillermo</creatorcontrib><creatorcontrib>Chávez, Zoé</creatorcontrib><creatorcontrib>Rivas-Alonso, Verónica</creatorcontrib><creatorcontrib>Corona, Teresa</creatorcontrib><creatorcontrib>Flores-Rivera, José</creatorcontrib><title>Obstetric outcomes in a Mexican cohort of patients with AQP4-antibody-seropositive neuromyelitis optica</title><title>Multiple sclerosis and related disorders</title><addtitle>Mult Scler Relat Disord</addtitle><description>•Close to half of the patients with previous pregnancies reported at least one gestational loss. This percentage is higher than expected for their age group in our country.•Most of these pregnancy losses occurred years before the diagnosis of NMO.•AQP4-IgG can be detected in serum more than 10 years before the NMO onset and can cause miscarriage by binding to placental AQP4, activating complement, and causing inflammatory infiltration. Background: Previous studies have investigated the influence of neuromyelitis optica (NMO) on pregnancy in other ethnic groups. However, there are potential variations among ethnic groups. The obstetric outcome of Mexican patients with NMO and AQP4-IgG positivity (AQP4-IgG[+]) is currently unknown. Objective: To describe the obstetric history of Mexican patients with NMO and AQP4-IgG(+). Methods: Patients with NMO and AQP4-IgG(+) were identified from the database of the Demyelinating Diseases Clinic. These patients were interviewed by telephone. Results: Out of a total of 40 eligible patients, 29 were contacted and completed the survey. Of these, 19 patients reported at least one previous pregnancy. In total, 50 pregnancies were reported: 44 of them occurred ≥ 3 years before the first clinical manifestation, 1 occurred ≥ 1 years before, and 1 occurred after the first manifestation. Of all pregnancies, 12 were pregnancy losses: 5 were classified as miscarriages and 3 as stillbirths. Of all pregnancy losses, 10 occurred ≥ 3 years before the diagnosis, 1 occurred after the first manifestation. All pregnancy losses occurred in 8 patients. Conclusions: Close to half of the patients with previous pregnancies reported at least one pregnancy loss, most of these occurred ≥ 3 years before the diagnosis. This percentage is higher than expected for their age group in our country.</description><subject>Abortion</subject><subject>Adult</subject><subject>Aquaporin 4</subject><subject>Aquaporin 4 - immunology</subject><subject>Autoantibodies - blood</subject><subject>Female</subject><subject>Hispanics</subject><subject>Humans</subject><subject>Immunologic Factors - adverse effects</subject><subject>Mexico - epidemiology</subject><subject>Middle Aged</subject><subject>Neuromyelitis optica</subject><subject>Neuromyelitis Optica - blood</subject><subject>Neuromyelitis Optica - complications</subject><subject>Neuromyelitis Optica - drug therapy</subject><subject>Obstetric Labor Complications - epidemiology</subject><subject>Obstetric Labor Complications - etiology</subject><subject>Pregnancy</subject><subject>Pregnancy complications</subject><subject>Pregnancy outcome</subject><subject>Spontaneous abortion</subject><issn>2211-0348</issn><issn>2211-0356</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kE1rGzEQhkVpaEySX1AIOvayzmj1Ye8hB2OaJpCSBNqz0EqzjYx3tZW0Sf3vK8epjx0GZgbeeYd5CPnMYM6AqavNvE8munkNbDmHkkx-ILO6ZqwCLtXHYy-Wp-QipQ2UUJIJxT6RUw5MNBz4jPx6aFPGHL2lYco29JioH6ih3_GPt2agNjyHmGno6GiyxyEn-urzM109PYrKDNm3we2qhDGMIfnsX5AOOMXQ73BbxkTDmIvROTnpzDbhxXs9Iz9vvv5Y31b3D9_u1qv7ynLZ5Ao7CcCwUwuQwpnGNq21TnWuAViI1iwW0jglXdcw5DWDpTINF62qLatN1wp-Rr4cfMcYfk-Ysu59srjdmgHDlHQNjZSi5ktZpPwgtTGkFLHTY_S9iTvNQO8h641-g6z3kDWUZPuty_cDU9ujO-78Q1oE1wcBljdfPEadbOFm0fmINmsX_H8P_AXYn5AA</recordid><startdate>201810</startdate><enddate>201810</enddate><creator>Delgado-García, Guillermo</creator><creator>Chávez, Zoé</creator><creator>Rivas-Alonso, Verónica</creator><creator>Corona, Teresa</creator><creator>Flores-Rivera, José</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3123-5879</orcidid></search><sort><creationdate>201810</creationdate><title>Obstetric outcomes in a Mexican cohort of patients with AQP4-antibody-seropositive neuromyelitis optica</title><author>Delgado-García, Guillermo ; Chávez, Zoé ; Rivas-Alonso, Verónica ; Corona, Teresa ; Flores-Rivera, José</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c359t-ef5001ef67054da9c9bccd6fd90074ba775ad65df91e321086a934b62c12afb43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Abortion</topic><topic>Adult</topic><topic>Aquaporin 4</topic><topic>Aquaporin 4 - immunology</topic><topic>Autoantibodies - blood</topic><topic>Female</topic><topic>Hispanics</topic><topic>Humans</topic><topic>Immunologic Factors - adverse effects</topic><topic>Mexico - epidemiology</topic><topic>Middle Aged</topic><topic>Neuromyelitis optica</topic><topic>Neuromyelitis Optica - blood</topic><topic>Neuromyelitis Optica - complications</topic><topic>Neuromyelitis Optica - drug therapy</topic><topic>Obstetric Labor Complications - epidemiology</topic><topic>Obstetric Labor Complications - etiology</topic><topic>Pregnancy</topic><topic>Pregnancy complications</topic><topic>Pregnancy outcome</topic><topic>Spontaneous abortion</topic><toplevel>online_resources</toplevel><creatorcontrib>Delgado-García, Guillermo</creatorcontrib><creatorcontrib>Chávez, Zoé</creatorcontrib><creatorcontrib>Rivas-Alonso, Verónica</creatorcontrib><creatorcontrib>Corona, Teresa</creatorcontrib><creatorcontrib>Flores-Rivera, José</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Multiple sclerosis and related disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Delgado-García, Guillermo</au><au>Chávez, Zoé</au><au>Rivas-Alonso, Verónica</au><au>Corona, Teresa</au><au>Flores-Rivera, José</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Obstetric outcomes in a Mexican cohort of patients with AQP4-antibody-seropositive neuromyelitis optica</atitle><jtitle>Multiple sclerosis and related disorders</jtitle><addtitle>Mult Scler Relat Disord</addtitle><date>2018-10</date><risdate>2018</risdate><volume>25</volume><spage>268</spage><epage>270</epage><pages>268-270</pages><issn>2211-0348</issn><eissn>2211-0356</eissn><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>content type line 23</notes><abstract>•Close to half of the patients with previous pregnancies reported at least one gestational loss. This percentage is higher than expected for their age group in our country.•Most of these pregnancy losses occurred years before the diagnosis of NMO.•AQP4-IgG can be detected in serum more than 10 years before the NMO onset and can cause miscarriage by binding to placental AQP4, activating complement, and causing inflammatory infiltration. Background: Previous studies have investigated the influence of neuromyelitis optica (NMO) on pregnancy in other ethnic groups. However, there are potential variations among ethnic groups. The obstetric outcome of Mexican patients with NMO and AQP4-IgG positivity (AQP4-IgG[+]) is currently unknown. Objective: To describe the obstetric history of Mexican patients with NMO and AQP4-IgG(+). Methods: Patients with NMO and AQP4-IgG(+) were identified from the database of the Demyelinating Diseases Clinic. These patients were interviewed by telephone. Results: Out of a total of 40 eligible patients, 29 were contacted and completed the survey. Of these, 19 patients reported at least one previous pregnancy. In total, 50 pregnancies were reported: 44 of them occurred ≥ 3 years before the first clinical manifestation, 1 occurred ≥ 1 years before, and 1 occurred after the first manifestation. Of all pregnancies, 12 were pregnancy losses: 5 were classified as miscarriages and 3 as stillbirths. Of all pregnancy losses, 10 occurred ≥ 3 years before the diagnosis, 1 occurred after the first manifestation. All pregnancy losses occurred in 8 patients. Conclusions: Close to half of the patients with previous pregnancies reported at least one pregnancy loss, most of these occurred ≥ 3 years before the diagnosis. This percentage is higher than expected for their age group in our country.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>30149303</pmid><doi>10.1016/j.msard.2018.08.015</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-3123-5879</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 2211-0348
ispartof Multiple sclerosis and related disorders, 2018-10, Vol.25, p.268-270
issn 2211-0348
2211-0356
language eng
recordid cdi_proquest_miscellaneous_2095542385
source ScienceDirect Journals
subjects Abortion
Adult
Aquaporin 4
Aquaporin 4 - immunology
Autoantibodies - blood
Female
Hispanics
Humans
Immunologic Factors - adverse effects
Mexico - epidemiology
Middle Aged
Neuromyelitis optica
Neuromyelitis Optica - blood
Neuromyelitis Optica - complications
Neuromyelitis Optica - drug therapy
Obstetric Labor Complications - epidemiology
Obstetric Labor Complications - etiology
Pregnancy
Pregnancy complications
Pregnancy outcome
Spontaneous abortion
title Obstetric outcomes in a Mexican cohort of patients with AQP4-antibody-seropositive neuromyelitis optica
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-21T12%3A47%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Obstetric%20outcomes%20in%20a%20Mexican%20cohort%20of%20patients%20with%20AQP4-antibody-seropositive%20neuromyelitis%20optica&rft.jtitle=Multiple%20sclerosis%20and%20related%20disorders&rft.au=Delgado-Garc%C3%ADa,%20Guillermo&rft.date=2018-10&rft.volume=25&rft.spage=268&rft.epage=270&rft.pages=268-270&rft.issn=2211-0348&rft.eissn=2211-0356&rft_id=info:doi/10.1016/j.msard.2018.08.015&rft_dat=%3Cproquest_cross%3E2095542385%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c359t-ef5001ef67054da9c9bccd6fd90074ba775ad65df91e321086a934b62c12afb43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2095542385&rft_id=info:pmid/30149303&rfr_iscdi=true